Use of streptavidin to inhibit transplant rejection
OwnerRashid A. Fawwazinventor
Life of this patent
Estimating the term…
Abstract
This invention provides methods and articles of manufacture for inhibiting the immunological rejection of a transplant in a subject. The instant methods and articles are based on the use of streptavidin for inhibiting such rejection.
Claims26
A method for inhibiting the immunological rejection of a transplant in a subject which comprises administering to the subject, at a suitable time, a prophylactically effective amount of streptavidin.
A pharmaceutical composition comprising streptavidin and a pharmaceutically acceptable carrier.
An article of manufacture comprising a packaging material having streptavidin therein, wherein the packaging material comprises a label indicating that the streptavidin is intended for use in inhibiting the immunological rejection of a transplant in a subject.
An article of manufacture comprising a packaging material having therein, either separately or in combination, streptavidin and anti-lymphocyte antibody, wherein the packaging material comprises a label indicating that the streptavidin and anti-lymphocyte antibody are intended for use in inhibiting the immunological rejection of a transplant in a subject.
Dependencies are inferred from the claim text.